BRIEF published on 06/08/2026 at 21:05, 13 days 16 hours ago Oxurion annonce sa stratégie logicielle avec Exagis Stratégie De Croissance Logiciel Recherche Clinique Oxurion Exagis
PRESS RELEASE published on 06/08/2026 at 21:00, 13 days 16 hours ago Oxurion launches a software-driven growth strategy with Exagis Oxurion NV announces the software-driven growth strategy launch centered on Exagis, its proprietary clinical research platform. The platform evolves into a broad CDMS commercially serving clinical development market Oxurion NV Exagis Clinical Research Platform Software-driven Growth Strategy CDMS
PRESS RELEASE published on 06/08/2026 at 21:00, 13 days 16 hours ago Oxurion lance une stratégie de croissance axée sur le logiciel avec Exagis Oxurion annonce une stratégie de croissance logicielle centrée sur sa plateforme Exagis pour la recherche clinique, visant une évolution vers un écosystème logiciel complet Recherche Clinique Plateforme Logicielle Oxurion Exagis Croissance Logicielle
PRESS RELEASE published on 06/08/2026 at 21:00, 13 days 16 hours ago Oxurion lanceert een softwaregedreven groeistrategie met Exagis Oxurion NV kündigt die Einführung einer softwaregesteuerten Wachstumsstrategie für sein klinisches Forschungsplattform Exagis an. Die Plattform wird separat kommerzialisiert, um Softwareeinnahmen zu generieren Wachstumsstrategie Oxurion NV Klinische Forschung Exagis Softwaregesteuert
BRIEF published on 06/03/2026 at 18:05, 18 days 19 hours ago Oxurion Annonce les Résultats de son Assemblée Générale Annuelle Assemblée Générale Investissements Résultats Pharmaceutique Oxurion
BRIEF published on 06/03/2026 at 18:05, 18 days 19 hours ago Oxurion approuve l'ordre du jour de son assemblée générale annuelle des actionnaires Déclarations Prospectives Assemblée Générale Des Actionnaires Oxurion NV Louvain Approbation De L'ordre Du Jour
BRIEF published on 06/03/2026 at 18:05, 18 days 19 hours ago Oxurion Announces the Results of its Annual General Meeting Pharmaceutical Investments General Assembly Results Oxurion
BRIEF published on 06/03/2026 at 18:05, 18 days 19 hours ago Oxurion Approves Agenda at Annual Shareholders' Meeting Forward-looking Statements Shareholders' Meeting Oxurion NV Leuven Agenda Approval
PRESS RELEASE published on 06/03/2026 at 18:00, 18 days 19 hours ago Oxurion Announces Results on the Annual Shareholders' Meeting of 1 June 2026 Oxurion NV (Euronext Brussels: OXUR) successfully held its annual shareholders' meeting in Leuven, with all agenda items approved. Find more about the biopharmaceutical company at oxurion.com Biopharmaceutical Euronext Brussels Annual Shareholders' Meeting Oxurion NV Leuven
PRESS RELEASE published on 06/03/2026 at 18:00, 18 days 19 hours ago Oxurion kondigt resultaten aan van de Jaarlijkse Aandeelhoudersvergadering van 1 juni 2026 Oxurion NV houdt succesvolle jaarlijkse aandeelhoudersvergadering waar alle agenda-items zijn goedgekeurd. Meer informatie beschikbaar op de website. Toekomstgerichte verklaringen van kracht Oxurion NV Aandeelhoudersvergadering Europese Farmaceutische Onderaannemers Toekomstgerichte Verklaringen
Published on 06/22/2026 at 13:00, 51 minutes ago NOA Lithium Signs Term Sheet for Option and Joint Venture with Summit Explore for Arizaro Project
Published on 06/22/2026 at 13:00, 51 minutes ago CoTec Holdings Corp. Notes HyProMag USA Advancement of Texas Hub and U.S. Magnet Platform
Published on 06/22/2026 at 13:00, 51 minutes ago Leggett Dynamics Launches Mid-Class Massage System & Makes Luxury Comfort Accessible on High-Volume Programs
Published on 06/22/2026 at 12:00, 1 hour 51 minutes ago CTT Pharma Signs LOI for Clinical Trials and Testing of Nicotine Products
Published on 06/22/2026 at 11:00, 2 hours 51 minutes ago American Critical Minerals Mobilizes to the Green River Project to Commence Drill Pad Construction
Published on 06/22/2026 at 13:40, 10 minutes ago Aroundtown SA: Release of a capital market information
Published on 06/22/2026 at 13:32, 18 minutes ago EQS-Adhoc: Aumann increases price of share buyback offer to €17.80 per share
Published on 06/22/2026 at 12:36, 1 hour 14 minutes ago Vienna Stock Exchange Admits SMRX Share of Emerald Horizon AG to Trading
Published on 06/22/2026 at 12:15, 1 hour 35 minutes ago OLB exercises previously announced right to call AT-1 bond
Published on 06/22/2026 at 12:05, 1 hour 45 minutes ago Geely Farizon, WeRide and Kwoon Chung Launch Right-Hand-Drive Robotaxis at 2026 International Automotive & Supply Chain Expo (Hong Kong), Accelerating Global Expansion
Published on 06/22/2026 at 08:30, 5 hours 21 minutes ago Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 5 hours 21 minutes ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 18 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 18 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 18 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
